Interesting idea if it works low molecular weight versions of peptides that can target varying types of tumours (Respiratory/CVS/Metabolic) with the benefit of ‘tuning’ of PK  profiles

>>>>

http://www.pharmatimes.com/news/az,_bicycle_pair_up_to_develop_bicyclic_peptides_1179714?utm_source=PT+Daily+Newsletter&utm_medium=email&utm_campaign=pt+daily+news+alert